Autres langues Kyowa Corporation

Actions

6570

JP3254830007

Loisirs et détente

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 24/07/2026			Varia. 5j.	Varia. 1 janv.
2 005,00 ^JPY	-0,35%		+3,94%	+66,94%

05/06/24	Kyowa Kirin rachète 3,3 millions d'actions en mai	MT
07/05/24	Le bénéfice de Kyowa Kirin en hausse de 15 % au premier trimestre	MT

Autres langues

12/11	Kyowa Corporation agreed to acquire DORAKU Co., Ltd. from Kosae Nishimura and Keisuke Yoshimura.
05/06/24	Kyowa Kirin Repurchases 3.3 Million Shares in May
07/05/24	Kyowa Kirin's Profit Up 15% in Q1
06/05/24	Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April
02/05/24	BridgeBio Pharma Shares Decline After Q1 Financial Results
03/04/24	Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March
25/03/24	Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed
25/03/24	Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation
20/03/24	Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag
18/03/24	EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria
18/03/24	US approves first gene therapy for children with rare genetic disease
05/03/24	Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares
08/02/24	China Deflation, Bank of Japan Roil Asian Stock Markets
08/02/24	MÄRKTE ASIEN/Tokio sehr fest auf 34-Jahreshoch - Softbank mit Kurssprung
08/02/24	Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar
08/02/24	Japan's Nikkei leaps to 2-week high on tech stocks, yen boost
07/02/24	BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan
07/02/24	Kyowa Kirin's Profit Up 52% in Fiscal 2023
26/01/24	Japanese Shares Skid as Inflation Slows Faster-than-Expected in January
26/01/24	Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics
24/01/24	Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin
23/01/24	Aosaikang Pharmaceutical Registers Breast Cancer Drug
02/11/23	Kyowa Kirin’s Attributable Profit up 8.8% in Nine Months Ended Sept. 30 on Gain on Sales of Share and Valuation
30/10/23	LATE BRIEFING - Unternehmen und Märkte
30/10/23	MIDDAY BRIEFING - Unternehmen und Märkte